DE60023915D1 - Replikationsprotein-a-bindendes transkriptionsfaktor (rbt1) und dessen verwendungen - Google Patents
Replikationsprotein-a-bindendes transkriptionsfaktor (rbt1) und dessen verwendungenInfo
- Publication number
- DE60023915D1 DE60023915D1 DE60023915T DE60023915T DE60023915D1 DE 60023915 D1 DE60023915 D1 DE 60023915D1 DE 60023915 T DE60023915 T DE 60023915T DE 60023915 T DE60023915 T DE 60023915T DE 60023915 D1 DE60023915 D1 DE 60023915D1
- Authority
- DE
- Germany
- Prior art keywords
- rbt1
- replication protein
- transcription factor
- binding transcription
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 102000018780 Replication Protein A Human genes 0.000 title abstract 4
- 108010027643 Replication Protein A Proteins 0.000 title abstract 4
- 102000040945 Transcription factor Human genes 0.000 title 1
- 108091023040 Transcription factor Proteins 0.000 title 1
- 101000880124 Homo sapiens SERTA domain-containing protein 3 Proteins 0.000 abstract 2
- 102100037366 SERTA domain-containing protein 3 Human genes 0.000 abstract 2
- 239000002773 nucleotide Substances 0.000 abstract 2
- 125000003729 nucleotide group Chemical group 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 102000018779 Replication Protein C Human genes 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000001415 gene therapy Methods 0.000 abstract 1
- 230000001613 neoplastic effect Effects 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108091006106 transcriptional activators Proteins 0.000 abstract 1
- 230000002103 transcriptional effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14947299P | 1999-08-19 | 1999-08-19 | |
| US149472P | 1999-08-19 | ||
| PCT/CA2000/000948 WO2001014546A2 (en) | 1999-08-19 | 2000-08-17 | Replication protein a binding transcriptional factor (rbt1) and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE60023915D1 true DE60023915D1 (de) | 2005-12-15 |
| DE60023915T2 DE60023915T2 (de) | 2006-08-10 |
Family
ID=22530436
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60023915T Expired - Fee Related DE60023915T2 (de) | 1999-08-19 | 2000-08-17 | Replikationsprotein-a-bindendes transkriptionsfaktor (rbt1) und dessen verwendungen |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1206542B1 (de) |
| AT (1) | ATE309354T1 (de) |
| AU (1) | AU6675900A (de) |
| CA (1) | CA2377730A1 (de) |
| DE (1) | DE60023915T2 (de) |
| WO (1) | WO2001014546A2 (de) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU3583797A (en) * | 1996-06-28 | 1998-01-21 | Regents Of The University Of California, The | Enhancement of cancer cell death |
| WO1998037901A1 (en) * | 1997-02-28 | 1998-09-03 | Boehringer Ingelheim Pharmaceuticals, Inc. | Self-regulated apoptosis of inflammatory cells by gene therapy |
-
2000
- 2000-08-17 EP EP00954207A patent/EP1206542B1/de not_active Expired - Lifetime
- 2000-08-17 WO PCT/CA2000/000948 patent/WO2001014546A2/en active IP Right Grant
- 2000-08-17 AT AT00954207T patent/ATE309354T1/de not_active IP Right Cessation
- 2000-08-17 AU AU66759/00A patent/AU6675900A/en not_active Abandoned
- 2000-08-17 DE DE60023915T patent/DE60023915T2/de not_active Expired - Fee Related
- 2000-08-17 CA CA002377730A patent/CA2377730A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU6675900A (en) | 2001-03-19 |
| ATE309354T1 (de) | 2005-11-15 |
| DE60023915T2 (de) | 2006-08-10 |
| WO2001014546A2 (en) | 2001-03-01 |
| CA2377730A1 (en) | 2001-03-01 |
| WO2001014546A3 (en) | 2001-11-29 |
| EP1206542A2 (de) | 2002-05-22 |
| EP1206542B1 (de) | 2005-11-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1140840A4 (de) | -g(v)-carboxyaryl substituierte diphenyl harnstoffe als raf kinase inhibitoren | |
| BG104599A (en) | Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas | |
| DE69826695D1 (de) | Arylharnstoffderivate zur behandlung von inflammatorischen oder immunomodulatorischen erkrankungen | |
| JO2373B1 (en) | W-carboxy-aryl diphenyl urease substitutes used as RAV inhibitors | |
| IL136738A0 (en) | Inhibition of p38 kinase activity using substituted heterocyclic ureas | |
| NO326660B1 (no) | Imidazolyl-cykliske acetal forbindelser, farmasøytiske sammensetninger inneholdende disse forbindelser og anvendelse av forbindelsene | |
| NO961888D0 (no) | Peptidylforbindelser og deres terapeutiske anvendelse som inhibitorer av metallproteinaser | |
| ATE357509T1 (de) | Stimulierung von hämatopoietischen zellen im vitro | |
| ATE380548T1 (de) | Verwendung von p53 inhibitoren zur behandlung von nebenerscheinungen bei der krebstherapie | |
| DE69828408D1 (de) | Naphthyridinone zur hemmung der durch protein-tyrosin-kinase und zellzyklus kinase hervorgerufenen zellvermehrung | |
| NO20000752D0 (no) | Metode for forhindring eller behandling av østrogen-avhengige sykdommer og forstyrrelser | |
| GR3035593T3 (en) | Combination of necrosis inducing substances with substances which are activated by necrosis for the selective treatment of tumours and or inflammatory diseases | |
| BG103832A (en) | Leptin as tumour cells proliferation inhibitor | |
| MXPA02007899A (es) | Citoquinas modificadas para utilizarse en terapia de cancer. | |
| DE60036105D1 (de) | Herpes-simplex virus, das das gen von interleukin-12 exprimiert, und dessen verwendung zur behandlung von krebs | |
| GB0418388D0 (en) | Cell therapy | |
| MXPA03000979A (es) | Moleculas tipo receptor de complemento c3b/c4b y usos de las mismas. | |
| MXPA05004074A (es) | Nuevos adenovirus, acidos nucleicos que los codifican y su uso. | |
| DE60023915D1 (de) | Replikationsprotein-a-bindendes transkriptionsfaktor (rbt1) und dessen verwendungen | |
| WO2003094967A3 (en) | New combination of reversible proton pump inhibitors and airway therapeutics for treating airway disorders | |
| WO2001036680A3 (en) | METHODS OF PREPARING cRNA | |
| MXPA03006742A (es) | Uso de buprenorfina para la terapia de la incontinencia urinaria. | |
| WO2002101076A3 (en) | Methods for targeted expression of therapeutic nucleic acid | |
| ATE310100T1 (de) | Screeningverfahren für modulatoren von methyltransferase abhängiger chromosomenstabilität | |
| ATE383154T1 (de) | Kombinierte tumortherapie auf der basis von distamycin-acryloyl derivaten und radiotherapie |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |